Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07698886 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description expanded, about 3 wordsv7
  2. Study description expanded, about 85 wordsv6
  3. Study description shortened, about 3 wordsv5
  4. Eligibility criteria revisedv4
  5. Recruitment opened
    • Start date: Jul 15, 2026 to Jul 16, 2026
    v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 1, 2026 to Jul 15, 2026
    • Site details revised
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.
Trial Details
NCT Number NCT07698886
Lead Sponsor KTH Biopharma
Conditions
(from sponsor)		 HPV (Human Papillomavirus)-Associated, Genital Warts
Related terms Condylomata Acuminata, Papillomavirus Infections
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov